All posts by: Michael Zand

About Michael Zand

iBio, Inc. (IBIO) Announces US Patent Granted to AzarGen … – StreetInsider.com

Continue reading

2017-07-12 NEWS

Weekly Register

iBio, Inc. (IBIO) Announces US Patent Granted to AzarGen …
StreetInsider.com
Get access to the best calls on Wall Street with StreetInsider.com’s Ratings Insider Elite. Get your Free Trial here. AzarGen Biotechnologies (Pty) Ltd …
Collaboration Partner Pulls Ibio Inc (NYSEMKT:IBIO) Higher – Stock …StockNewsUnion

all 4 news articles »

Continue reading

2017-07-12 NEWS

Business Insider

First gene therapy on the cusp of FDA approval
Pharmacy Today, American Pharmacists Association, pharmacist.com
An FDA advisory panel will make the call July 12 to recommend for or against agency approval of the first gene therapy. A favorable decision could see the regulator sanction the treatment by early this fall. Drug manufacturer Novartis and the
FDA panel to focus on safety of Novartis gene therapy drug …Business Insider
Novartis’ CAR-T Therapy for Pediatric Leukemia to Face FDA Advisory PanelAJMC.com Managed Markets Network

all 13 news articles »

Continue reading

2017-07-12 NEWS

BioTechniques.com

INJECTING NANOPARTICLES INTO IMMUNOTHERAPY
BioTechniques.com
This is the delicate balance that makes immunotherapy tricky. “The immune system is always integrating all these signals. It’s never on or off. It’s just always a balance,” says Christopher Jewell, a chemical engineer at the University of Maryland in

Continue reading

2017-07-12 NEWS

Science Magazine

A stem cell transplant helped beat back a young doctor’s cancer. Now, it’s assaulting his body
Science Magazine
Stem cells from his brother’s marrow reconstituted his blood cells, including immune system cells, and within a year, Wartman was working full time and running regularly. “I was almost back to my baseline,” he says, as his runs gradually lengthened and

Continue reading

2017-07-12 NEWS

Science Magazine

A stem cell transplant helped beat back a young doctor’s cancer …
Science Magazine
Graft-versus-host disease is an often debilitating consequence of a common leukemia cure.

and more »

Continue reading

2017-07-12 NEWS

US Patent Granted to AzarGen Biotechnologies for Synthetic Promoter Technology
PR Newswire (press release)
AzarGen has recently been featured on CB Insights’ top global synthetic biology start-up companies market map list. AzarGen also recently expanded its collaboration with iBio, Inc. (NYSE MKT: IBIO), a leader in developing plant-based biopharmaceuticals

Continue reading

2017-07-12 NEWS

CBS News

FDA panel to vote on revolutionary gene therapy for cancer
CBS News
July 12, 2017, 8:13 AM | An FDA panel meets Wednesday to decide whether to recommend the first government-approved gene therapy. CAR T-cell treatment uses the body’s own immune system to attack cancer. USC Norris Westside Cancer Center director …